TELA Bio, Inc.
TELA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001561921
In the last 90 days, TELA Bio, Inc. insiders filed 4 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $19.3M in total; no superinvestor holds it.
Holders of 5% or more of TELA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of TELA Bio, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ew Healthcare Partners Fund 2, L.P. | 13D | 17.23%7.71M shares | −0.09 ppfrom 17.32% | Feb 18, 20217 filings | Jun 9, 2026 | SEC |
| Nantahala Capital Management, LLC | 13G/A | 12.94%5.79M shares | +0.04 ppfrom 12.90% | Nov 14, 20244 filings | Aug 14, 2026 | SEC |
| North Run Capital, LP | 13G/A | 9.30%3.68M shares | +4.30 ppfrom 5.00% | May 30, 20252 filings | May 30, 2025 | SEC |
| Stonepine Capital Management, LLC | 13G/A | 6.00%2.35M shares | – | Feb 13, 20251 filing | Feb 13, 2025 | SEC |
| Lytton Laurence W | 13G/A | 5.50%2.44M shares | −1.70 ppfrom 7.20% | Aug 14, 20253 filings | May 15, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
30 Schedule 13D and 13G filings on TELA Bio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:39 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 12.94%5.79M shares | +0.04 ppfrom 12.90% | Jun 30, 2026 | SEC |
| Aug 14, 202612:53 PM ET | Silverarc Capital Management, LLCand 1 other | 13G/A | 4.80%2.14M shares | 0.00 ppfrom 4.80%Below 5% | Jun 30, 2026 | SEC |
| Aug 11, 202610:44 AM ET | Silverarc Capital Management, LLCand 1 other | 13G | 4.80%2.14M shares | −3.00 ppfrom 7.80%Below 5% | Jun 30, 2026 | SEC |
| Jun 9, 20266:29 PM ET | Ew Healthcare Partners Fund 2, L.P.and 3 others | 13D | 17.23%7.71M shares | −0.09 ppfrom 17.32% | Jun 9, 2026 | SEC |
| May 15, 20261:05 PM ET | Lytton Laurence W | 13G/A | 5.50%2.44M shares | −1.70 ppfrom 7.20% | Mar 31, 2026 | SEC |
| Nov 17, 20254:26 PM ET | Ew Healthcare Partners Fund 2, L.P.and 3 others | 13G/A | 17.32%7.71M shares | – | Nov 17, 2025 | SEC |
| Nov 14, 20252:12 PM ET | Lytton Laurence W | 13G/A | 7.20%2.87M shares | −1.30 ppfrom 8.50% | Sep 30, 2025 | SEC |
| Oct 15, 20255:12 PM ET | Grow Funds, LLC. | 13G/A | – | – | Sep 30, 2025 | SEC |
| Aug 14, 20253:08 PM ET | Lytton Laurence W | 13G/A | 8.50%3.42M shares | – | Jun 30, 2025 | SEC |
| May 30, 20254:03 PM ET | North Run Capital, LPand 6 others | 13G/A | 9.30%3.68M shares | +4.30 ppfrom 5.00% | Mar 31, 2025 | SEC |
| May 30, 20254:00 PM ET | North Run Capital, LPand 6 others | 13G | 5.00%1.98M shares | New | Jan 24, 2025 | SEC |
| May 8, 20257:57 AM ET | Hirschman Orinand 1 other | 13G/A | 3.60%1.42M shares | −3.20 ppfrom 6.80%Below 5% | Mar 31, 2025 | SEC |
| May 7, 20254:31 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 12.90%5.11M shares | +2.91 ppfrom 9.99% | Apr 30, 2025 | SEC |
| Feb 14, 20254:32 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 9.99%3.97M shares | +2.24 ppfrom 7.75% | Dec 31, 2024 | SEC |
| Feb 13, 202512:07 PM ET | Stonepine Capital Management, LLCand 3 others | 13G/A | 6.00%2.35M shares | – | Dec 31, 2024 | SEC |
| Feb 12, 20253:54 PM ET | Silverarc Capital Management, LLCand 1 other | 13G | 7.80%3.07M shares | New | Dec 31, 2024 | SEC |
| Jan 31, 20254:05 PM ET | Hirschman Orinand 1 other | 13G/A | 6.80%2.66M shares | – | Dec 31, 2024 | SEC |
| Nov 14, 20244:53 PM ET | Nantahala Capital Management, LLCand 2 others | 13G | 7.75%1.92M shares | New | Sep 30, 2024 | SEC |
| Jul 30, 20245:50 PM ET | Grow Funds, LLC. | 13G | 5.70%1.40M shares | New | Jul 24, 2024 | SEC |
| Feb 28, 2022 | Ew Healthcare Partners Fund 2, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Pura Vida Investments, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Quaker BioVentures II LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Jan 19, 2022 | Ew Healthcare Partners Fund 2, L.P. | 13D/AOld format | – | – | – | SEC |
| Sep 21, 2021 | Ew Healthcare Partners Fund 2, L.P. | 13D/AOld format | – | – | – | SEC |
| Jun 21, 2021 | Pura Vida Investments, LLC | 13GOld format | – | New | – | SEC |
| May 18, 2021 | Ew Healthcare Partners Fund 2, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 18, 2021 | Ew Healthcare Partners Fund 2, L.P. | 13DOld format | – | New | – | SEC |
| Feb 12, 2021 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Jan 26, 2021 | Quaker BioVentures II LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell TELA Bio, Inc. shares.
No Form 144 notices for TELA Bio, Inc. are on file.